Screening for Nasopharyngeal Carcinoma

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Transrapid, Flugtaxis, Hyperloop – Warum es neuartige Verkehrstechnik so schwer hat 28 min · 22 Sep 2026 · Das Wissen | SWR

September 21, 2026: FAA Resolves Air Traffic Outage, Paramount Reaches Settlement, More 7 min · 22 Sep 2026 · Bloomberg News Now

Los 3 Casos Más Extraños de Relatos de la Noche 43 min · 22 Sep 2026 · Relatos de la Noche

The Ed Sheeranisation of Irish Economic Policy 39 min · 22 Sep 2026 · The David McWilliams Podcast

How can I stop my plants from dying? 5 min · 22 Sep 2026 · Do you really know?

Could smartphone use be giving you text neck? 4 min · 22 Sep 2026 · Do you really know?

Report any issue

Source

Recorded07 Dec 2023

Publisherfeeds.buzzsprout.com

Handlerec:1648206

Show notes

Jacob Miller, MD, a Radiation Oncologist at Cleveland Clinic, joins the Cancer Advances podcast to share his insights on nasopharyngeal carcinoma (NPC) screening and his trial presented at the American Society of Radiation Oncology (ASTRO) 2023 Annual Meeting. NPC is rare in the United States but prevalent in Southern China, primarily caused by the Epstein-Barr virus (EBV). Listen as Dr. Miller explains his screening trial that resulted in earlier-stage diagnoses and improved outcomes, as well as lessons from this research that may inform screening strategies for other cancers.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in